Evaluation of the GORE® Ascending Stent Graft
A trial with no phase registered on ClinicalTrials.gov. The registry status is enrolling by invitation. It plans to enroll 370 participants.
Also called NCT05800743
- Study
- In this atlas
Overview
- Design
- Interventional study; non-randomized; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 370 participants
- Sponsor
- Registry
-
NCT05800743
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- United States
- Registry status
- Enrolling by invitation
Technical summary
Registry record NCT05800743. Non-randomized; no masking; primary purpose treatment. Start 2023-11-28 (actual); primary completion 2029-10 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Evaluation of the GORE® Ascending Stent Graft
- Acronym
- ARISEII
- Condition
- Aortic Aneurysm, Thoracic
- Condition
- Pseudoaneurysm
- Condition
- Aortic Dissection
- Condition
- Aorta; Lesion
- Intervention (Device)
- GORE® Ascending Stent Graft (ASG device)
- Intervention (Device)
- GORE® Thoracic Aortic Graft Thoracic Branch Endoprosthesis (TBE Device)
- Intervention (Procedure)
- Surgery
- Lead sponsor
- W.L.Gore & Associates
Record details
- Record id
cardio:ct-nct05800743- Content hash
6e1503a38f5a588a228f640dead0d8d9751d0844c02225ae467a2060a588467f